Therapy-related acute myeloid leukemia following treatment with trabectedin for Ewing's sarcoma.

about

Therapy-related acute myeloid leukemia following treatment with trabectedin for Ewing's sarcoma.

Item

http://www.wikidata.org/entity/Q45988744

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

2011年學術文章

@zh-hant

name

Therapy-related acute myeloid ...... abectedin for Ewing's sarcoma.

@en

Therapy-related acute myeloid ...... abectedin for Ewing's sarcoma.

@nl

type

Item

label

Therapy-related acute myeloid ...... abectedin for Ewing's sarcoma.

@en

Therapy-related acute myeloid ...... abectedin for Ewing's sarcoma.

@nl

prefLabel

Therapy-related acute myeloid ...... abectedin for Ewing's sarcoma.

@en

Therapy-related acute myeloid ...... abectedin for Ewing's sarcoma.

@nl

P1476

Therapy-related acute myeloid ...... rabectedin for Ewing's sarcoma

@en

P2093

Amir Tahbaz

http://www.w3.org/2001/XMLSchema#string

Dan Douer

http://www.w3.org/2001/XMLSchema#string

Susan Zneimer

http://www.w3.org/2001/XMLSchema#string

P2860

Trabectedin for metastatic soft tissue sarcoma: a retrospective single center analysis.

Efficacy and safety of trabectedin in patients with advanced or metastatic liposarcoma or leiomyosarcoma after failure of prior anthracyclines and ifosfamide: results of a randomized phase II study of two different schedules.

Nucleotide-resolution mapping of topoisomerase-mediated and apoptotic DNA strand scissions at or near an MLL translocation hotspot

Poisoning of human DNA topoisomerase I by ecteinascidin 743, an anticancer drug that selectively alkylates DNA in the minor groove.

A phase II study of Yondelis (trabectedin, ET-743) as a 24-h continuous intravenous infusion in pretreated advanced breast cancer

Rearrangements of the MLL gene are influenced by DNA secondary structure, potentially mediated by topoisomerase II binding.

Cleavage of the MLL gene by activators of apoptosis is independent of topoisomerase II activity.

In vitro antitumor activity of the novel marine agent, ecteinascidin-743 (ET-743, NSC-648766) against human tumors explanted from patients.

Topoisomerase II inhibitors induce DNA double-strand breaks at a specific site within the AML1 locus.

Trabectedin plus pegylated liposomal Doxorubicin in recurrent ovarian cancer.

P304

76-78

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1159/000324936

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

126

http://www.w3.org/2001/XMLSchema#string

P50

Stephen V Liu

P577

2011-04-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21502754

http://www.w3.org/2001/XMLSchema#string

P921

therapy-related acute myeloid leukemia